EcoDrugPlus

Estrogen Receptor 1

Ensembl ID : ENSEEEG00000013622
Gene Symbol: ESR1
4 Cross references
215 Possible Orthologues:

Estrogen Receptor 2a

Ensembl ID : ENSEEEG00000005464
Gene Symbol: ESR2A
4 Cross references
200 Possible Orthologues:

Estrogen Receptor 2b

Ensembl ID : ENSEEEG00000012770
Gene Symbol: ESR2B
4 Cross references
208 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSEEEG00000020812
Gene Symbol: ESRRGA
4 Cross references
201 Possible Orthologues:

Exportin 1

Ensembl ID : ENSEEEG00000005037
Gene Symbol: XPO1
2 Cross references
166 Possible Orthologues:

Exportin 1

Ensembl ID : ENSEEEG00000017098
Gene Symbol: XPO1
4 Cross references
227 Possible Orthologues:

Farnesyl Diphosphate Synthase (Farnesyl Pyrophosphate Synthetase, Dimethylallyltranstransferase, Geranyltranstransferase)

Ensembl ID : ENSEEEG00000012857
Gene Symbol: FDPS
4 Cross references
269 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSEEEG00000021012
Gene Symbol: FDFT1
4 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSEEEG00000015535
Gene Symbol: FNTA
4 Cross references
222 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSEEEG00000013459
Gene Symbol: FNTB
4 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSEEEG00000001091
Gene Symbol: FGFR1A
4 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSEEEG00000021417
Gene Symbol: FGFR2
4 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).